"moderate" MCQ (SBA): Respiratory Medicine

Instant feedback + full explanation. One question, done properly.

Moderate"NHLBI/NAEPP 2020 focused updates recommend either daily low‑dose ICS with as‑needed SABA or as‑needed ICS taken with SABA for mild persistent asthma. A: SABA‑only is no longer sufficient for persistent disease. C: Less effective. D: LABA monotherapy is contraindicated. E: Systemic steroids are not controller therapy."Respiratory Medicine"moderate"

A 35-year-old with mild persistent asthma (symptoms >2 days/week, normal FEV₁) seeks controller therapy. According to NAEPP 2020 updates, which option is recommended?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

"moderate" MCQ: Respiratory Medicine — Answer & Explanation | iatroX